Chongqing Genrix Biopharmaceutical Co (SHSE:688443) FCF Margin %: -292.08% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688443 Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
43 GF Score
Price ¥25.12
! 4 Warning Signs
View Full Analysis

What is Chongqing Genrix Biopharmaceutical Co FCF Margin %?

Chongqing Genrix Biopharmaceutical Co SHSE:688443 +1.17% 43 FCF Margin % is -292.08% as of Mar. 2026. GuruFocus rates SHSE:688443 with a GF Score™ of 43/100. The stock has 4 warning signs investors should review. Among 950 Biotechnology companies, Chongqing Genrix Biopharmaceutical Co ranks worse than 59.89% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Chongqing Genrix Biopharmaceutical Co's Free Cash Flow for the three months ended in Mar. 2026 was ¥-196.4 Mil. Chongqing Genrix Biopharmaceutical Co's Revenue for the three months ended in Mar. 2026 was ¥67.2 Mil. Therefore, Chongqing Genrix Biopharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2026 was -292.08%.

As of today, Chongqing Genrix Biopharmaceutical Co's current FCF Yield % is -5.44%.

The historical rank and industry rank for Chongqing Genrix Biopharmaceutical Co's FCF Margin % or its related term are showing as below:

SHSE:688443' s FCF Margin % Range Over the Past 10 Years
Min: -756935.48   Med: -18087.87   Max: -180.34
Current: -180.34

During the past 7 years, the highest FCF Margin % of Chongqing Genrix Biopharmaceutical Co was -180.34%. The lowest was -756935.48%. And the median was -18087.87%.

SHSE:688443's FCF Margin % is ranked worse than
59.89% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs SHSE:688443: -180.34

Chongqing Genrix Biopharmaceutical Co FCF Margin % Related Terms

Chongqing Genrix Biopharmaceutical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Chongqing Genrix Biopharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chongqing Genrix Biopharmaceutical Co FCF Margin % Chart

Chongqing Genrix Biopharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -894.41 -68,178.32 -38,660.07 -2,062.65 -183.48

Chongqing Genrix Biopharmaceutical Co Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -589.06 -151.19 -98.80 -458.42 -292.08

SHSE:688443 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's FCF Margin % falls into.


SHSE:688443
43GF Score
Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chongqing Genrix Biopharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Chongqing Genrix Biopharmaceutical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-423.327/230.727
=-183.48 %

Chongqing Genrix Biopharmaceutical Co's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-196.418/67.247
=-292.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -292.08% mean?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a FCF Margin % of -292.08% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Chongqing Genrix Biopharmaceutical Co and its competitors. According to the industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #569 out of 950 companies in the Biotechnology industry, placing it in the top 59.9%.
Is Chongqing Genrix Biopharmaceutical Co's FCF Margin % too high?
Chongqing Genrix Biopharmaceutical Co's current FCF Margin % is -292.08%. Based on the distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #569 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Chongqing Genrix Biopharmaceutical Co has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Chongqing Genrix Biopharmaceutical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chongqing Genrix Biopharmaceutical Co ranks #569 out of 950 companies for FCF Margin %. This places Chongqing Genrix Biopharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Chongqing Genrix Biopharmaceutical Co and its competitors. Chongqing Genrix Biopharmaceutical Co's current FCF Margin % is -292.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Genrix Biopharmaceutical Co stock overvalued right now?
Chongqing Genrix Biopharmaceutical Co (SHSE:688443) has a current FCF Margin % of -292.08%. The current FCF Margin % is -292.08%. Chongqing Genrix Biopharmaceutical Co's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Chongqing Genrix Biopharmaceutical Co (SHSE:688443), the current FCF Margin % is -292.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chongqing Genrix Biopharmaceutical Co Business Description

Address No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan District, Chongqing, CHN, 401338
Chongqing Genrix Biopharmaceutical Co Ltd is a biopharmaceutical company engaged in the research & development, production and sales of antibody drugs. The company's pipeline includes product candidate that targets Autoimmune Diseases, Infectious Diseases, and Oncology.
43GF Score

Get the complete analysis for SHSE:688443

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.12
Price